Sobi - Swedish Orphan Biovitrum AB (publ) · 1 day ago
Head of Global Labeling Strategy
Maximize your interview chances
BiotechnologyGenetics
Insider Connection @Sobi - Swedish Orphan Biovitrum AB (publ)
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Provide oversight of product labeling at Sobi
Promotes partnerships with project/program teams to ensure key submission milestones are met
Sets functional goals which contribute to the departments vision and long-range planning
Leads a team of Global Labeling leads and Labeling Co-ordinator
Provides line management to direct reports including training, performance management, professional development and coaching
Provides excellent understanding of labeling requirements and guidance
Manages Sobi Executive Labeling Committee (ELC) and is responsible for follow-up on ELC decisions regarding labeling
Ensures that product labeling reflects a complete and accurate description of the risks and benefits of Sobi products based on available data
Ensures timely creation and updates of CDS that represent Sobi’s position on maximum efficacy and core safety of Sobi’s products and approval of CDS deviations
Provides oversight of labeling operations work including artwork and mock-up creation and updates
Makes decisions on administrative and operational matters and ensures the labeling team effectively achieves its objectives
Utilize strategic thinking and risk assessment capabilities in your area of responsibility
Maintain knowledge of global competitive landscape, regulatory environment, regulations, and best practices
Contribute to the development and maintenance of Regulatory Affairs working practices & procedures
Additional duties may be assigned, as needed
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
A University Degree in Life Sciences is required
10 years of industry experience of which at least 8 years of experience within Regulatory Affairs in a Labeling role
At least 5 years of formal people management
Diverse experience working with a variety of pharmaceutical products
Extensive experience working with regulatory labeling for Prescription medicines and interacting with Regulatory Agencies including the US FDA on labeling issues
Experience leading and managing updates to prescribing information
Extensive experience working in a global environment
Experience of leading projects and cross-functional teams
Extensive knowledge of Labeling regulations and guidance
Thorough knowledge of the drug development process, with a focus on IND and NDA processes
Above-average proficiency with basic technology tools (e.g. MS-Office, etc.)
Demonstrate excellent communication skills (oral/written/listening) in English
Results driven and team-oriented attitude with the ability to influence outcomes
Excellent organizational and time management skills to effectively manage multiple ongoing projects simultaneously
Proven ability to innovate, especially with analysing & solving problems, with minimal supervision and exceptionally keen skills for attention to detail
Proven success in simultaneously handling strategic and transactional responsibilities, especially in a small-team environment
Preferred
Knowledge of any other languages would be an asset
Benefits
Competitive compensation for your work
Emphasis on work/life balance
Collaborative and team-oriented environment
Opportunities for professional growth
Diversity and Inclusion
Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments
We offer a competitive benefits package, to support the health and happiness of our staff.
Company
Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$825.99M2024-05-08Post Ipo Debt· $274.92M
2023-08-22Post Ipo Equity· $551.07M
2006-09-15IPO· sto:SOBI
Leadership Team
Guido Oelkers
Chief Executive Officer
Recent News
Morningstar, Inc.
2024-11-15
2024-11-14
News Powered by Cision
2024-11-11
Company data provided by crunchbase